Bank of America’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-67,460
| Closed | -$270K | – | 7550 |
|
|
2019
Q4 | $270K | Buy |
67,460
+9,826
| +17% | +$46.2K | ﹤0.01% | 5432 |
|
|
2019
Q3 | $282K | Sell |
57,634
-40,273
| -41% | -$225K | ﹤0.01% | 5449 |
|
|
2019
Q2 | $596K | Sell |
97,907
-293,233
| -75% | -$1.56M | ﹤0.01% | 4939 |
|
|
2019
Q1 | $2.27M | Sell |
391,140
-108,649
| -22% | -$1.12M | ﹤0.01% | 3884 |
|
|
2018
Q4 | $6.73M | Sell |
499,789
-126,996
| -20% | -$2.14M | ﹤0.01% | 2689 |
|
|
2018
Q3 | $12.2M | Sell |
626,785
-701,391
| -53% | -$14.9M | ﹤0.01% | 2293 |
|
|
2018
Q2 | $33.9M | Buy |
1,328,176
+933,562
| +237% | +$21.8M | 0.01% | 1375 |
|
|
2018
Q1 | $7.95M | Sell |
394,614
-242,928
| -38% | -$5.67M | ﹤0.01% | 2629 |
|
|
2017
Q4 | $12.8M | Sell |
637,542
-119,758
| -16% | -$2.36M | ﹤0.01% | 2216 |
|
|
2017
Q3 | $15.7M | Buy |
757,300
+255,440
| +51% | +$4.32M | ﹤0.01% | 2080 |
|
|
2017
Q2 | $7.43M | Buy |
501,860
+79,163
| +19% | +$1.32M | ﹤0.01% | 2668 |
|
|
2017
Q1 | $6.74M | Buy |
422,697
+196,418
| +87% | +$2.83M | ﹤0.01% | 2750 |
|
|
2016
Q4 | $2.85M | Buy |
226,279
+107,294
| +90% | +$2M | ﹤0.01% | 3459 |
|
|
2016
Q3 | $3.33M | Buy |
118,985
+11,278
| +10% | +$378K | ﹤0.01% | 3203 |
|
|
2016
Q2 | $3.77M | Sell |
107,707
-7,035
| -6% | -$221K | ﹤0.01% | 3051 |
|
|
2016
Q1 | $3.14M | Sell |
114,742
-42,641
| -27% | -$1.26M | ﹤0.01% | 3186 |
|
|
2015
Q4 | $5.39M | Buy |
157,383
+100,884
| +179% | +$3.15M | ﹤0.01% | 2868 |
|
|
2015
Q3 | $1.62M | Buy |
56,499
+47,778
| +548% | +$2.04M | ﹤0.01% | 3947 |
|
|
2015
Q2 | $390K | Sell |
8,721
-4,264
| -33% | -$160K | ﹤0.01% | 4876 |
|
|
2015
Q1 | $449K | Buy |
12,985
+9,961
| +329% | +$271K | ﹤0.01% | 4394 |
|
|
2014
Q4 | $83K | Buy |
+3,024
| New | +$73.4K | ﹤0.01% | 6016 |
|
Other funds holding DPLO
Bank of America's DPLO Position: Q1 2020 in Review
Bank of America sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 67,460 shares — an estimated $270K sold.
Bank of America first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $33.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Bank of America reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 67,460 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $270K.
- Bank of America first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Bank of America's DIPLOMAT PHARMACY, INC. position peaked at $33.9M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.